Yang X., Li Y., Pan S., et al., Discovery of a Potent and Orally Bioavailable Xanthine Oxidase/Urate Transporter 1 Dual Inhibitor as a Potential Treatment for Hyperuricemia and Gout, Journal of Medicinal Chemistry 67 (2024): 1466814691, 10.1021/acs.jmedchem.4c01480
These differences matter
For this carcinogenesis model, single application of dimethylbenzanthracene (DMBA) led to the initiating of the oncogenic mutation of the HRAS gene
But not every new drug follows the above outline
Journal of Cosmetic Dermatology, 18(1), 2128. Overview of how peptides improve hydration, elasticity, and overall skin appearance
TFCE corrected) which estimated the group mean spatial distribution of [11C]Raclopride displacement using a one-tailed one-sample t -test